P61 Pooled analysis of objective cough frequency in participants with chronic cough treated with gefapixant in two phase 3 clinical trials (COUGH-1 and COUGH-2)
Smith, JA, Morice, A, McGarvey, L, Pavord, I, Birring, SS, Dicpinigaitis, P, Iskold, B, Li, Q, Tzontcheva, A, La Rosa, C, Muccino, D
Published in Thorax (08.11.2021)
Published in Thorax (08.11.2021)
Get full text
Journal Article
P59 Baseline characteristics and medical history of patients with refractory or unexplained chronic cough participating in two global phase 3 clinical trials
McGarvey, L, Birring, SS, Dicpinigaitis, P, Morice, A, Pavord, I, Smith, JA, Iskold, B, Li, Q, Martin Nguyen, A, Schelfhout, J, Tzontcheva, A, La Rosa, C, Muccino, D
Published in Thorax (08.11.2021)
Published in Thorax (08.11.2021)
Get full text
Journal Article
PRS45 - Development Of A Report Card For Identifying Local Sublingual Immunotherapy Events In Clinical Trials
Norquist, JM, Tanzosh, T, Flood, E, Li, H, Iskold, B, Ganser, TR, Marson-Smith, HR
Published in Value in health (01.05.2016)
Published in Value in health (01.05.2016)
Get full text
Journal Article
Development Of A Report Card For Identifying Local Sublingual Immunotherapy Events In Clinical Trials
Norquist, JM, Tanzosh, T, Flood, E, Li, H, Iskold, B, Ganser, TR, Marson-Smith, HR
Published in Value in health (01.05.2016)
Published in Value in health (01.05.2016)
Get full text
Journal Article